Used in biomedical research to detect and quantify integrin αⅤβ3 levels in cell lysates, tissue extracts, and biological fluids. This ELISA kit is particularly valuable in studies related to angiogenesis, cancer progression, and metastasis, as integrin αⅤβ3 is overexpressed in activated endothelial cells and many tumor cells. It supports research in drug development, especially for anti-angiogenic therapies and integrin-targeted inhibitors. The assay enables high sensitivity and specificity, allowing researchers to monitor changes in integrin expression under experimental conditions or in response to therapeutic agents.